Liposomal formulation of hypoxia activated prodrug for the treatment of ovarian cancer.
Shah VM, Nguyen DX, Al Fatease A, Patel P, Cote B, Woo Y, Gheewala R, Pham Y, Huynh MG, Gannett C, Rao DA, Alani AWG.
Shah VM, et al. Among authors: cote b.
J Control Release. 2018 Dec 10;291:169-183. doi: 10.1016/j.jconrel.2018.10.021. Epub 2018 Oct 16.
J Control Release. 2018.
PMID: 30339904